Introduction
Despite recent molecular cloning of several brain myosins (Bahler et al., 1994; Ruppert et al., 1993 ; Cheney et Neuronal growth cones guide axons in the developing al., 1993) and localization of myosins to growth cones nervous system toward distant target sites. Recent evi- (Rochlin, 1995; Espreafico et al., 1992 ; Cheng et al., dence suggests that growth cones decode both diffus-1992; Miller et al., 1992) , little or no information regarding ible and substrate-bound molecular signals during the functional role of myosins in growth cone motility the guidance process (Kennedy and Tessier-Lavigne, has emerged to date (cf. Tanaka, 1995 Tanaka, ). 1995 Tessier-Lavigne, 1992 ) that involves pathfinding, Given the functional implications of our previous work, branching, and ultimately, target recognition. All of these we designed experiments aimed at global inhibition of behaviors depend on precise regulation of growth cone myosin activity, to test whether any myosin was in fact motility. Bray pioneered investigation of growth cone involved in driving retrograde F-actin flow in growth motility and was the first to observe that inert particles cones. All known myosins have an evolutionarily conplaced on the growth cone surface moved in a retroserved N terminal head domain containing the ATP, grade direction, suggestive of an underlying centripetal F-actin-binding, and force generation sites (Mooseker membrane or actin filament flux (Bray, 1970) . Early studand Cheney, 1995) . Chymotryptic digestion of muscle ies also demonstrated that growth cone motility demyosin results in cleavage of a head domain subfragpended on actin filament assembly (Yamada and Wesment (S1) from the rest of the molecule (Margossian and sells, 1973) , and a critical role for actin assembly in Lowey, 1982) . S1 exhibits ATP-dependent actin filament axonal guidance emerged when it was shown that axons binding, but lacking the C terminal tail, is incapable of in the developing grasshopper nervous system lost all generating force unless artificially tethered (e.g., by an pathfinding capabilities when treated with cytochalasin antibody) to a substrate. In addition, further treatment of (Bentley et al., 1986) . Later, studies characterizing actin S1 with the sulfhydryl reagent, N-ethylmaleimide (NEM), dynamics in Aplysia growth cones in vitro suggested results in a myosin head species (NEM-S1) that remains that the retrograde flux mentioned above was actually tightly bound to actin filaments, even in the presence of ATP, and thus can serve as a potent specific inhibitor due to actin filament assembly at nucleation sites along The S1 proteins prepared for microinjection were fur- Table 1 . ATP-Dependent F-Actin Interactions with S1 and ther characterized by Western blot analysis ( Figure 1A ) and immunofluorescence on cultured neurons ( Figure   S1 NEM-S1 1B). When resolved by SDS-PAGE and stained with Coo-ATP (2 mM) Ϫ ϩ Ϫ ϩ massie Brilliant blue, purified S1 or NEM-S1 subfragPercent Protein cosedimented 95 Ϯ 1 7 Ϯ 1 81 Ϯ 8 75 Ϯ 3 ment preparations contained one major ‫001ف‬ kDa prowith actin filaments tein ( Figure 1A , lanes 1 and 3). A monoclonal antibody, F59, against the head domain of vertebrate skeletal muscle myosin-II, recognized this major protein and two of actomyosin function (Cande, 1986; Meeusen and other minor lower molecular weight species (lanes 2 Cande, 1979). Our first experimental approach was then and 4, Figure 1A) ; the latter are likely due to limited to competitively inhibit myosin function by injection of proteolysis of the S1 and NEM-S1 proteins; their conpurified S1 or NEM-S1, and look at effects on growth centrations were less than one tenth that of the ‫001ف‬ cone motility, actin dynamics, and structure. kDa protein species. In addition, Western blot analysis We then compared these results with those obtained of Aplysia CNS (lanes 5 and 6, Figure 1A ) and immunoafter treatment, with 2,3-butanedione-2-monoxime fluorescence of uninjected cultured Aplysia neurons (BDM), a pharmacological inhibitor of endogenous myo-(data not shown) with the F59 antibody resulted in essin ATPase activity. BDM has previously been shown to sentially no immunoreactivity, indicating that endogeeffect cross-bridge kinetics and inhibit both convennous Aplysia myosins were not recognized by F59. tional muscle and nonmuscle myosin ATPases, includMyosin antagonists were typically microinjected into ing myosin V, platelet myosin II, and a drosophila myosin the cell body (arrow, Figure 1B ), along with rhodamineATPase fraction, without affecting kinesin ATPase activdextran (10-40 kDa) as a volume indicator. Microinity or actin assembly (Backx et al., 1994; Cramer and jection of S1 or NEM-S1 proteins resulted in characteris- Mitchison, 1995; McKillop et al., 1994; Schramm et al., tic structural and functional effects on the peripheral 1994; Zhao and Kawai, 1994) . We show here that both growth cone lamella (Figure 1 ). These effects were assotypes of myosin inhibition result in essentially the same ciated with the presence of exogenous myosin proteins effects: attenuation of retrograde F-actin flow accompain the cell body and the growth cone region (dashed nied by filopodial, and leading edge extension at rates box, Figure 1B ) of the injected cell, as evidenced by directly proportional to the degree of flow inhibition.
positive labeling with the F59 antibody. Growth cones These experiments suggest that simple superimposiused for injection studies were typically <50 m away tion of two additive processes: actin polymerization, from the cell body, to facilitate rapid diffusion into the and the action of myosin motors underlie retrograde growth cone region. Control injections of buffer alone F-actin flow.
or rhodamine-dextran resulted in no obvious effects on growth cone motility or structure (data not shown). A Results typical example of the effects of S1 microinjection is shown in Figures 1C-1E . Progressive elongation of filoStructural and Functional Changes Induced podia was observed (white arrowheads; Figures 1C-1D ) by S1 or NEM-S1 Microinjection 3 min after injection of S1 protein. Rhodamine-phalloidin Table 1 summarizes the results of F-actin cosedimentastaining revealed a high concentration of actin filaments tion assays performed on S1 and NEM-S1 preparations.
in these newly extended filopodia ( Figure 1E ). S1 bound to F-actin in the absence but not in the pres-NEM-S1 injection resulted in similar effects; however, ence of ATP. The ATP-dependent release of S1 from NEM-S1 was more potent and its effects reversed more F-actin was nearly abolished by NEM-modification.
slowly than S1, as expected from the cosedimentation These results are consistent with previous reports on results. Under control conditions or immediately after NEM-modified heavy meromyosin (Meeusen and microinjection, the ruffling transition zone was typically Cande, 1979) . In control experiments where S1 or NEMsituated between the peripheral lamelipodium and the S1 proteins were centrifuged in the absence of actin central microtubule-rich cytoplasmic domain (Forscher filaments Ϯ ATP, no protein was detected in the pellet and Smith, 1988 ). Within ‫03ف‬ s of NEM-S1 microinjection injection, filopodia extended over time ( Figure 1F , open fraction (data not shown). Figure 1 . Effects of S1 and NEM-S1 Microinjection on Aplysia Growth Cones (A) Western blot analysis using F59 monoclonal antibody. Purified S1 (lanes 1 and 2), NEM-S1 (lanes 3 and 4), and protein preparation from whole Aplysia nervous tissue (lanes 5 and 6) were either stained with Coomassie Brilliant blue (lanes 1, 3, and 5) or probed with F59 antibody (lanes 2, 4, and 6). (B) S1 (or NEM-S1) protein was microinjected at the cell body (arrow). Injected protein revealed by F59 immunofluorescence; growth cone region: dashed box. (C and D) S1 subfragments at concentration of 7.9 mg/ml were injected into the cell shown at lower magnification in (B). DIC images of the growth cones taken before (C) and 3 min after microinjection (D). Note filopodia elongation (arrowheads). (E) Extended filopodia (arrowheads) contain actin filaments, as revealed by rhodamine-phalloidin staining (identical fields: [D] , [E] ). (F) Analysis of growth dynamics following NEM-S1 (2.9 mg/ml) microinjection. Note the initial progressive elongation of filopodia (open arrowheads) and subsequent retraction (closed arrowhead). Expansion of ruffling domain (asterisks) was also apparent. Time (in s) after microinjection is indicated. Bar represents 5 m.
(G) Retrograde F-actin flow is attenuated after NEM-S1 microinjection. Retrograde flow rates before and after microinjection of either rhodaminedextran control vehicle) or 4.2 mg/ml NEM-S1 were measured using flow-coupled bead markers. Time ϭ 0 min indicates NEM-S1 microinjection. arrowheads), and the ruffling transition zone often apinjection of NEM-S1 resulted in rapid dose-dependent peared to expand outward ( Figure 1F , white asterisks).
attenuation of retrograde flow (NEM-S1; Figure 5D ); the Initial rates of extension appeared similar for all filopodia retrograde flow rate decreased to 1.16 Ϯ 0.61 m/min within a given growth cone. In this example, the filopobetween 1-6 min after injection, and spontaneously redium indicated (white arrowheads) elongated during the covered to 4.47 Ϯ 1.01 m/min after ‫7ف‬ min. Table 2 first 105 s after injection, then shortened somewhat beand Figure 5D show dose-response data for NEM-S1 tween 105-150 s (closed arrowhead). The duration of injection experiments. Cellular NEM-S1 concentrations elongation varied, ranging from 1-10 min (N ϭ 17 experiwere estimated assuming ‫01/1ف‬ cell volume injections. ments), resulting in filopodia of different lengths. These effects tended to reverse spontaneously over time; however, filopodia shortening appeared to be much slower, Pharmacological Inhibition of Myosin occurring in a less synchronous manner than initial filoActivity Mimics S1 Microinjection podium elongation. Growth cones of NEM-S1 injected
To further investigate the effects of myosin inhibition on cells often exhibited leading edge extension; however, growth cones, we treated cells with BDM, a myosin the degree of extension tended to vary along the extent ATPase inhibitor. BDM treatment resulted in similar efof the leading edge, with more pronounced advance fects to those observed after S1 or NEM-S1 microinjectypically occurring toward the front of the growth cone.
tion: attenuation of retrograde flow accompanied by In NEM-S1 experiments where extension of filopodia rapid growth. Figure 2A demonstrates typical effects of and leading edge occurred simultaneously, the extent BDM treatment, including progressive filopodium elonof outgrowth was always more robust in filopodia than gation (arrowheads), leading edge extension (arrows), the leading edge (data not shown). Actin filament netand a slight retraction of the central cytoplasmic dowork geometry may be playing a role here; since filomain. Note the net widening of the lamellipodium during podia contain unidirectional actin filaments oriented BDM treatment. In the continuous presence of BDM, parallel with the direction of growth whereas lamellileading edge and filopodial advance typically continued podia are characterized by a less-polarized filament orfor 5-10 min, then gradually stopped, despite persistent ganization, filopodial protrusion driven by actin assemattenuation of retrograde flow. bly may be more efficient.
BDM treatment also resulted in dose-dependent atThe structural effects of NEM-S1 microinjection were tenuation of retrograde F-actin flow ( Figure 2B ). Maximal accompanied by attenuation of retrograde F-actin flow.
depth of flow attenuation occurred about 4 min after To measure F-actin flow rates, we utilized membranedrug application ( Figure 2B , shaded bars), and persisted bound flow-coupled beads previously demonstrated to as long as the drug was present. Retrograde flow recovbe reliable noninvasive markers for quantitating actin ered to control levels 5-6 min after BDM washout. Table network dynamics in this system (Lin and Forscher, 3 and Figure 5D show dose-response data pooled by 1995). Beads were rapidly positioned in the desired area normalizing flow rates measured 4 min after drug addiof interest using a laser trap, and average bead translotion by the control flow rates. Overall, BDM effects on cation rates were measured before and after NEM-S1 both structure and motility were strikingly similar to injection. A typical example is shown in Figure 1G . Conthose observed after either S1 or NEM-S1 injections (cf. trol flow rates before microinjection were 5.90 Ϯ 0.79 Figure 1 ). m/min (mean Ϯ SEM), and no significant change Structural effects of BDM on the growth cone cyto-(5.37 Ϯ 1.18 m/min) was observed in cells microinjected with rhodamine-dextran alone (vehicle). However, skeleton were further examined by visualization of (Figure 3 ). Over time, filopodia tended to elongate and Since myosin inhibition resulted in simultaneous attenuaccumulate F-actin. In contrast, microtubule distribution ation of retrograde F-actin flow and filopodium extenappeared to be relatively unperturbed even after prosion, we investigated how these two phenomena were longed BDM treatments. There also appeared to be a related. To quantitate F-actin movement, flow coupled gradual proximal to distal depletion of actin filaments bead markers were positioned with a laser trap at the in lamellipodia.
same location on the lamellipodium before and after myosin inhibition treatments, as in Figures 5A-5C . Note BDM or S1/NEM-S1 Induced Extension in this example that under control conditions, retrograde Depends on Actin Polymerization flow ( Figure 5B , black vector, rate ϭ 5.10 mm/min) is Filopodium and leading edge extension observed folaccompanied by essentially no filopodium extension lowing myosin inhibition could result either from actin (white dashed line). Two min after application of 10 mM assembly or translocation of preexisting actin filaments.
BDM, retrograde flow decreased to about 54% of the To differentiate between these two mechanisms, we control rate ( Figure 5C , black vector, rate ϭ 2.75 mm/ used cytochalasin B (CB) to inhibit barbed end actin min) and filopodium extension occurred (white dashed polymerization during BDM (Figure 4A ), or S1 microinline, rate ϭ 2.21 mm/min). Similar data analyses were jection (data not shown) induced filopodium elongation.
performed on growth cones treated with different conAs shown in Figure 4A , filopodium elongation was first centrations of BDM ( Figure 5E , open circles, 29 experitriggered by BDM treatment (white line, 0-40 s). Subsements) or microinjected with 2-4 mg/ml NEM-S1 that quently, exposure to 1M CB in the presence of BDM translates into intracellular protein concentrations of 2-4 immediately eliminated further filopodium extension mM assuming a ‫01/1ف‬ cell volume injections ( Figure 5E , (dashed line, 50-90 s). Finally, washout of CB in the closed squares, 17 experiments). Retrograde flow rates presence of BDM resulted in resumption of filopodial decreased with either increasing BDM dose or amount extension at nearly pre-CB rates (black line, 100-150 s).
of NEM-S1 protein injected ( Figure 5D ). When the doseThese results indicate that barbed end actin assembly response data from both types of inhibitor studies were drives the protrusive growth observed during BDM treatpooled and filopodium growth plotted against retroments and S1/NEM-S1 microinjections.
grade F-actin flow rates, an inverse linear relationship was apparent, strongly suggesting that filopodia growth and retrograde flow are simple additive processes with Actin Network Translocation during Cytochalasin opposite sign ( Figure 5E ).
Treatment Is Myosin-Dependent
Our previous work demonstrated a characteristic patDiscussion tern of persistent retrograde actin network retraction during cytochalasin treatment (described above and in Myosin(s) Drives Retrograde F-Actin Flow Forscher and Smith, 1988; Lin and Forscher, 1993) , sugin Neuronal Growth Cones gesting that the translocation aspect of retrograde flow
In this study, we present two independent lines of evidid not depend on actin assembly. To examine the role dence that retrograde F-actin flow in growth cones is of myosin in this response, we observed the effects of driven by a myosin-type molecular motor: competitive BDM treatment on F-actin network movement in the inhibition by injection of purified S1 or NEM inactivated absence of actin assembly. Since the onset of BDM myosin head domain subfragments (NEM-S1), and phareffects are slower than CB ‫0.3ف(‬ versus ‫52.0ف‬ min remacological inhibition of myosin ATPase activity with spectively), growth cones were pretreated with BDM to BDM. Both treatment regimes resulted in strikingly simiattenuate retrograde flow before addition of CB (Figure lar effects on growth cone motility and structure, specifi-4B, note nonlinear time points shown in individual pancally, dose-dependent attenuation of retrograde F-actin els, asterisks). After 1 min in 30 mM BDM, filopodium flow accompanied by marked filopodial, and in the case elongation was apparent ( Figure 4B, 2 min, arrowhead) of BDM, leading edge growth. The significance of each and substantial slowing of retrograde flow was obof these effects will be examined below. served. At this point, CB was added and combined CB/ Both S1 and NEM-S1 compete with endogenous myo-BDM treatment resulted in slow retraction of F-actin sin(s) for actin filament binding sites, and can thus be from the leading edge (bars indicate F-actin free gap used as tools for studying actomyosin function. Because formation). Note that retraction rates in CB/BDM were NEM-S1 binds actin filaments essentially irreversibly, it very slow in the 2-5 min interval, and then stalled comshould be a more potent competitive antagonist as was pletely during the 5-9 min interval. This 4 min stall period observed here. In contrast with the S1 or NEM-S1 protein is significant since under control conditions, it typically reagents that directly interact with actin filaments, evitakes less than 3 min for a filament at the leading margin dence suggests that BDM is a general myosin ATPase to transverse the entire lamellipodium. At 9 min, myosin inhibitor (Cramer and Mitchison, 1995;  Higuchi and Tainhibition was relieved by BDM wash out and resulted kemori, 1989; Schramm et al., 1994; Steinen et al., 1995) . in retraction of residual actin networks (9-13 min). Note BDM is thought to act by stabilizing the weak actinthat retraction resumed (in CB) at 4.85 m/min, which binding myosin-ADP·P i intermediate state (Herrmann et is similar to retrograde flow rates observed under control al., 1992) and has seen wide used in muscle physiology conditions (Forscher and Smith, 1988) . The growth cone (Alpert et al., 1989; Fryer et al., 1988; Gwathmey et al., 1992; Horiuti et al., 1988; Steele and Smith, 1993 ; Tung fully recovered after CB washout (20 min recovery). , 1985; West and Stephenson, 1989) , where, not side effects? A parallel concern with competitive inhibitors is that although their site of action may be specific, surprisingly, it acts as a relaxant.
A major concern with pharmacological agents such secondary effects may be incurred by displacement of proteins other than the targeted effector molecule; for as BDM is specificity of action: are there contaminating example, NEM-S1 might displace actin binding proteins both were working through a common effector, i.e., myosin(s). involved in regulation of actin dynamics and/or network structure. In this study, we found that both types of High concentrations (>50 mM) or long term (>30 min) BDM treatments were accompanied by progressive demyosin inhibition scheme (S1/NEM-S1 or BDM treatment) led to nearly identical structural changes and efcreases of F-actin content in lamellipodia (Figure 3 ). In addition, although retrograde flow was inhibited as long fects on growth cone motility. This occurred despite the disparate mechanisms of action embodied by the two as the BDM was present ( Figure 2B ), filopodia extension occurred predominantly in the first 15 min after drug treatments. It is highly unlikely that we would observe such similar effects from such dissimilar agents unless application. These observations raise the issue of BDM side effects on actin metabolism. Cramer and Mitchison actin filaments and the acto-S1 complexes appear to function as hyperstable actin nucleation sites (Miller et (1995) have recently shown that overnight treatment with 20 mM BDM had no effect on in vitro actin assembly, al., 1988) . This property of S1 does not really affect our interpretation of the effects of S1/NEM-S1 on retrograde and we show here that filopodial protrusion induced by 10 mM BDM was due to continued barbed end assembly flow; however, it does raise the possibility that the filopodial growth we observe might be simply due to poten-( Figure 4A ). These observations make it unlikely that the decreased flow rates we observed shortly after BDM tiation of actin assembly by S1 or NEM-S1. As mentioned above, BDM has little or no effect on in vitro actin assemtreatment resulted from actin related side effects. We also noted that the ED 50 for BDM mediated retrograde bly (Cramer and Mitchison, 1995) , yet BDM treatment consistently led to robust leading edge and filopodial flow attenuation was slightly higher than that recently reported for inhibition of postmitotic spreading in PtK2 extension (e.g., Figure 2A ). Although we can not rule out permissive effects of S1 or NEM-S1 on actin assembly, cells (Cramer and Mitchison, 1995) . This difference likely reflects lower BDM solubility in the high salt marine the simple inverse proportionality of the growth versus flow plot for both BDM and NEM-S1 ( Figure 5E ) suggests saline (ASW) used here than in the lower ionic strength PBS used in the PtK2 study.
that the major initial effect of both treatments is simply slowing of retrograde flow that leads to proportional Finally, the pattern of F-actin signal decay over time after BDM treatment that can be seen in Figure 3 is filopodial growth. Finally, why BDM would elicit leading edge growth more reliably than S1/NEM-S1 injections worth a short comment. Under control conditions retrograde flow delivers actin filaments to the proximal transiis not clear. One possibility is that lamellipodia are more easily disrupted than filopodia by agents (like S1 or tion zone at a rate of ‫001ف‬ nm/s (Mitchison and Kirschner, 1988; Smith, 1988) . To maintain steady state, NEM-S1) capable of interfering with actin cross linking proteins. the growth cone must take apart or "recycle" these networks approximately as fast as they arrive (cf. Figure  Do myosin motors or actin assembly limit the rate of retrograde flow? A flow-coupled bead will move steadily 6B). It is likely that this filament recycling involves severing and a yet uncharacterized accelerated disassemrearward over time, and is not affected by nearby leading edge and filopodia protrusions and retractions (P. F. and bly process, since it is too fast to be accounted for by simple actin disassembly rates measured in vitro C. H. L., unpublished data). This supports the contention that protrusion (assembly) and retrograde flow are un- (Pollard, 1986; Pollard and Cooper, 1986) . In any case, the anterograde spreading decay of lamellar F-actin coupled processes, and also that actin assembly rates can transiently exceed those of retrograde flow. That over time we observe might result from continued action of the filament recycling process in the absence of retroactin assembly can drive motility at rates in excess of retrograde flow was independently demonstrated durgrade flow.
ing previous characterization of a focal actin assembly response, triggered by highly charged polycationic Actin Assembly Drives Protrusion and Myosin beads applied to the growth cone surface (Forscher et Drives Retrograde Flow Independently al., 1992) . In this case, actin assembly led to generation Both S1/NEM-S1 and BDM treatments resulted in modof F-actin tails similar to those formed by invasive bacteerate leading edge extension and marked filopodial ria such as Listeria monocytogenes (Theriot et al., growth (Figures 1-3 ) that was totally and reversibly in1992b). We showed that actin assembly could drive hibited by low doses of cytochalasin (Figure 4) , demonbead translocation at up to four times the average retrostrating that protrusive growth can be accounted for by grade flow rate. Thus, it seems fairly clear that actin barbed end actin filament assembly without invoking assembly rates do not limit retrograde flow, and further alternative mechanisms, such as actin filament sliding. studies on myosin regulatory mechanisms in growth In addition, we found that retrograde movement of (recones appear to be in order. sidual) actin networks in CB was reversibly inhibited by BDM ( Figure 4B ), indicating that in the absence of actin assembly, retrograde movement of F-actin depends Significance of the Inverse Growth Versus Retrograde Flow Relationship critically on myosin motor action, as originally proposed (Forscher and Smith, 1988) . These complimentary exAplysia growth cones exhibit a spatially uniform pattern of retrograde F-actin flow and advance very slowly when periments demonstrate that protrusive growth and retrograde flow are experimentally separable processes, they are not interacting with target substrates (Lin and Forscher, 1995) . Although the naming convention may and suggest that the respective underlying mechanisms of actin assembly and myosin powered network retracdiffer, a wide variety of motile cells also exhibit centripetal flux, cortical flow, or retrograde flow of F-actin. Detion are independent. If the latter suggestion were true, growth and retrograde flow would be expected to be spite its ubiquitous presence and speculations regarding its importance, the mechanism of retrograde flow additive processes of opposite sign; i.e., they would be inversely proportional. Indeed, when filopodial growth has been elusive (Bray and White, 1988; Cramer et al., 1994; Heath and Holifield, 1991) . The results of the preswas plotted versus retrograde flow under varying degrees of myosin inhibition, an inverse linear relationship ent study help fill this gap in our knowledge, and suggest a surprisingly simple steady state model can account was readily apparent (Figure 5 ). It should also be noted here that previous studies have shown that S1 can profor the salient features of the retrograde flow. Since both filopodial and lamellipodial F-actin ( Figure 6A ) appear mote actin assembly in vitro (Grazi et al., 1980; Detmers et al., 1981) . S1 exhibits 1:1 stochiometric binding to to move in concert (Lin and Forscher, 1995) , we treat them as a single kinetic unit and make the simplifying assumptions depicted in Figure 6B . Under control conditions, we observe slow growth and robust retrograde flow; actin filaments are moved away from the leading edge by myosin action about as fast as they are assembled ( Figure 6B, control) . When myosin is inhibited, retrograde flow slows and we observe growth in direct proportion to the degree of flow attenuation ( Figure 6B , myosin inhibited). Note that this "growth" involves a net widening of the peripheral domain (cf. Figure 2A) , and thus differs markedly from the physiological growth we observe during growth cone target interactions . In the latter case, synchronous and directed advance of both central microtubule and peripheral lamellar domains is observed, enabling the growth cone to maintain structural equilibrium, despite dramatic increases in its net growth rate.
In contrast with growth cones, which at best advance relatively slowly, cells such as keratocytes can translocate approximately as fast as actin is assembled at their leading margin; therefore, although constant centripetal actin flux in the cell's reference frame occurs, there is little or no retrograde F-actin flow, with respect to an external substrate reference (Theriot and Mitchison, 1991; Theriot and Mitchison, 1992a) . It is thought that keratocytes and other highly motile cells employ highly efficient adherence mechanisms to limit actin slippage and thereby keep retrograde flow to a minimum (Lee et al., 1993; Lee et al., 1994) . Interestingly, we have recently shown that when growth cones interact with a favorable growth substrate, retrograde flow slows in direct proportion to increased rates of both leading edge and axonal microtubule advance (Lin and Forscher, 1995) . We suspect that in this case, flow attenuation results from stabilization of newly assembled actin filaments, with respect to the target substrate by adhesion complexes that may act somewhat like a molecular clutch (Lin et al., 1994; Tanaka, 1995) . Note this would not only promote the protrusive growth observed, but in the context of the present study would appear to engage the actomyosin force generation system, perhaps allowing the growth cone to pull the distal axon toward the target substrate.
In the context of directed axonal growth, it is interesting to note that the central domain appeared to recede slightly during myosin inhibition experiments (cf. Figure  2A) , and microtubule distribution did not appear to be markedly affected (Figure 3 ). This kind of response is tors. Motors are bound to a reference frame stable with respect to an external substrate reference (shaded box). Extracellular flow coupled beads move in synchrony with retrograde F-actin flow (gray arrow). Newly assembled F-actin is shaded. Myosin Inhibition attenuates both retrograde flow and bead movement resulting in protrusive growth due to maintained F-actin assembly. Rates of growth and retrograde F-actin flow are inversely proportional. , 1995 Forscher and Smith, 1988) , aging in culture, motility were observed after 1% DMSO treatment (data not shown).
exposure to phototoxic light levels, osmotic shock, and perturbation of actin structure by various pharmacologi-
Microinjection
The microinjection protocol was described previously (Lin and cal agents, result in microtubule extension, rather than Forscher, 1995) . Briefly, bag cell neurons were transferred to a cus-
recession. An intriguing possibility suggested by these tom-made injection chamber, then the cell bodies were impaled observations is that actomyosin interactions in the with a glass pipette mounted on a 3D hydraulic micromanipulator growth cone promote microtubule extension either by (Narashigi USA) retrofitted with a piezoelectric axial drive (Burleigh tensioning microtubules or by a less direct mechanism Instruments, Fishers, NY) under video-enhanced-DIC observation.
(cf. Figure 6C ). Clearly, this would be advantageous durPurified S1 or NEM-S1 proteins at concentrations of 2-8 mg/ml were loaded in the injection needle together with 0.5 mg/ml 10 kDa ing growth cone target interactions when highly directed were typically ‫%01ف‬ of cell volume.
These results provide the first functional evidence that myosin motors are involved in generating retrograde
Immunoblots and Immunofluorescence flow in growth cones. Given the structural makeup of For fluorescent staining of the cytoskeleton, cells were first fixed F-actin in the growth cone, the force generation mechawith 4% freshly made paraformaldehyde in isotonic ASW supplemented with 400 mM sucrose (pH 7.6) nism might involve localized activation and contraction After fixation, cells were permeabilized for 2-5 min in fixation buffer of myosin molecules intercalated into the less-ordered plus 0.5% Triton-ϫ X 0, washed with PBS, and stained with rhodalamellar actin networks, or myosins interacting with the mine-phalloidin (Molecular Probes) in PBS. Cells were then washed unipolar actin filament arrays in filopodia ( Figure 6C ).
with PBS, exposed to 5% bovine serum albumin-PBS, followed by
The functional implications of this study provide a strong PBS, and examined immediately. To localize microinjected S1 or NEM-S1 proteins, F59, a monoclonal antibody made against the Experimental Procedures head domains of skeletal muscle myosin (provided by Dr. Frank Stockdale, Stanford University) was used. Culture supernatant from Preparation of Proteins the hybridoma cell line was diluted 1:50 for primary antibody incubaSkeletal muscle myosin was purified from chicken pectoralis mustion. For immunoblot analysis, purified S1 and NEM-S1 proteins or cle, according to the method of Kielley and Harrington (1959) . Actin whole protein preparation from Aplysia nervous tissue were resolved was purified from an acetone powder of chicken skeletal muscle, on a 5%-16% SDS-PAGE gel, transferred to nitrocellulose paper, according to the method of Spudich and Watt (1971) . S1 proteolytic and then probed with F59 monoclonal antibody at 1:250 dilution fragments were prepared from myosin digested with 50 g/ml and secondary antibody conjugated with alkaline phosphatase. ␣-chymotrypsin in the presence of 1 mM EDTA-K (Margossian and Lowey, 1982) ; protease activity was inhibited by addition of 1 mM Surface Markers and Micro-Positioning Pefabloc (Boheringer Mannheim, Indianapolis, IN). NEM-S1 was proTo prepare flow-coupled beads for retrograde flow rate measureduced by incubating S1 at 5-10 mg/ml in 50 mM KCl, 20 mM imidament, 200-500 nm polystyrene beads (Polyscience, Warrington, PA) zole-Cl (pH 7.2), 1 mM EDTA-K, and 0.1 mM DTT, with 1.0 mM or silica beads (Bangs Laboratory Incorporated, Carmell, IN) were freshly dissolved NEM at room temperature for 20 min. The reaction either coated with polyethyleneimine (Sigma; Forscher and Smith, was stopped by adding DTT to a final concentration of 10 mM; 1990; Lin and Forscher, 1995) or derivatized with avidin followed unreacted NEM was removed by dialysis (Meeusen and Cande, by biotinylated Concanavalin A (Vector Laboratory Incorporated, 1979) . Cytochalasin B (CB) and BDM were purchased from Sigma Burlingame, CA). Beads were then incubated for 10 min in artificial Chemical Company (St. Louis, MO). sea water (ASW) supplemented with 1 mg/ml BSA blocking protein before application to cells to inhibit possible triggering of subjacent F-Actin Cosedimentation Assay F-actin assembly by beads (inductopodia formation, see Forscher G-actin at a final concentration of 250 g/ml (6 mM) was induced et al., 1992 ). An infrared single beam gradient optical trap (Svoboda to polymerize by addition of KCl to a final concentration of 75 mM and Block, 1994) was used to repeatedly position beads at the same and MgCl 2 to 2.5 mM in a 10 mM imidazole, 1 mM EGTA buffer. S1 location on the growth cone lamella before and after treatments or NEM-S1 at a final concentration of 150 g/ml (1.5 mM) were then inhibiting myosin activity. The laser trap employed a 150 mW laser added to the F-actin solution either in the absence or in the presence diode emitting at 790 nm, as previously described (Lin and Forscher, of 2 mM Mg-ATP. As controls, reactions containing only S1 or NEM-1995). S1 without F-actin, or F-actin alone, were also performed. The reactions were incubated at room temperature for 20 min, then centriKinetic Analysis of Retrograde F-Actin Flow fuged at 100,000 X g for 45 min at 15ЊC. Equal amounts of the Kinetic analysis was done using programs developed in this laboraresulting supernatants and pellets were resolved on a 5%-16% tory (Forscher et al., 1992; Lin and Forscher, 1993 ; Lin and Forscher, SDS-PAGE and then stained with Coomassie Brilliant blue. The gel 1995). To quantitate the changes in retrograde F-actin flow, flowwas then scanned and digitized using a Scanmaker III (Microtek coupled beads were placed over the entire angular extent of the Laboratory Incorporated, Redondo Beach, CA), and densitometry growth cone lamella before and after S1 or NEM-S1 microinjection was performed using Band Leader (Internet ShareWare, Ma'ayan or BDM treatment. Translocation rates of individual beads (indicative Aharoni). Average values are shown in Table 1 from three experiof underlying F-actin flow rates) were measured during bead transments using three separate protein preparations. port on the lamella between the leading edge and the proximal transition zone using 5 s sampling intervals. Data was pooled from Cell Culture, Solutions, and Video Microscopy all beads attached to the growth cone membrane at any given time Cell culture and video microscopy techniques as previously described (Forscher and Smith, 1988; Lin and Forscher, 1993; point; resulting average rates were then plotted as a function of time.
